Careers  |  Sign In  |  Register  |   Twitter

Epilepsy: New Medications

Lacosamide, Rufinamide and Vigabatrin

Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses recent medications that have been introduced to the market for the treatment of seizures.

Owns stock, stock options, or bonds from: GlaxoSmithKline

For more information on Dr. Wilner, Please visit: